ASTRO ROCKS: 2022 ASTRO-Myovant Sciences-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge
Category
  • Non Clinical Skills
Format
  • Webinars
Credits
  • 1.00 Certificate of Attendance
ASTRO ROCKS: NCI Diversity Supplements and Other Awards Targeting Underrepresented Populations
Category
  • Non Clinical Skills
Format
  • Webinars
Credits
  • 0.00 Certificate of Attendance
ASTRO ROCKS: The NCI Mentored Clinical Scientist Research Career Development Award (K08)
Category
  • Non Clinical Skills
Format
  • Webinars
Credits
  • 0.00 Certificate of Attendance
ASTRO ROCKS: The NCI Small Business Innovation Research/Technology Transfer (SBIR/STTR) Programs
Category
  • Non Clinical Skills
Format
  • Webinars
Credits
  • 0.00 Certificate of Attendance
ASTRO ROCKS: The NCI Research Program Projects (P01) Mechanism
Category
  • Non Clinical Skills
Format
  • Webinars
Credits
  • 0.00 Certificate of Attendance
ASTRO ROCKS: Transitioning from Mentored to Independent Research
Category
  • Non Clinical Skills
Format
  • Webinars
Credits
  • 0.00 Certificate of Attendance
ASTRO ROCKS: ASTRO-Industry Radiation Oncology Research Training Fellowships: Building the Competitive Edge for a Career to Bridge Academia and Industry for the Advancement of Medicine
Category
  • Non Clinical Skills
Format
  • Webinars
Credits
  • 0.00 Certificate of Attendance
Advancing Our Multi-Disciplinary Understanding of the Cardiovascular Considerations with Radiation Therapy
While radiation therapy (RT) is a highly effective treatment for many solid tumors, thoracic RT carries a risk of cardiovascular (CV) morbidity and mortality that limits critical gains in cancer control and survival.
Category
  • Other
  • Patient Safety
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
ASTRO/ESTRO Joint Session – Overview of ASTRO/ESTRO Oligometastatic NSCLC Clinical Practice Guidelines: Case-Based Interactive Discussion
One of the most exciting and rapidly evolving areas of radiation oncology is in its application to the settings of oligometastatic or metastatic disease. Some of the most significant progress has been in implementing local therapy in the management of oligometastatic NSCLC.
Category
  • Other
  • Lung Cancer
Format
  • CME only
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Science Highlights 2023: Gastrointestinal Cancer
This session highlights the most clinically relevant abstracts within the Gastrointestinal Cancer track of the 2023 ASTRO Annual Meeting scientific program.
Category
  • Gastrointestinal Cancer
Format
  • Science Highlights
  • CME only
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Certificate of Attendance

Pages